Trending Health

Vynamic

Tune in each week for in-depth discussions on the topics we think industry leaders should be considering, along with monthly healthcare news round-ups (Trending News US and Trending News Europe). read less
BusinessBusiness
ScienceScience
ManagementManagement
MarketingMarketing
Life SciencesLife Sciences

Episodes

Pioneering the Future: Cancer Breakthroughs and Customer Experience Excellence
2d ago
Pioneering the Future: Cancer Breakthroughs and Customer Experience Excellence
In this episode, Jack, Jen, and Ollie discuss recent newsworthy items, including a roundup of key insights from the NEXT Pharma Summit, AstraZeneca’s announcements at ASCO, and the NHS’s groundbreaking trials for personalised cancer vaccines.Podcast Tags: healthcare, healthcare news, NEXT Pharma Summit, life sciences, Novartis, generative AI, Lilly, omnichannel, AstraZeneca, Tagrisso, lung cancer, ASCO, NHS, vaccine Source Links: Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference ASCO: AstraZeneca\’s Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation ASCO24: AstraZeneca won cancer’s big meeting — again. Will that help it fulfill its $80 billion ambition? ASCO Daily Recap: AstraZeneca’s hat trick, a GSK turnaround, and palliative care as telehealth At ASCO, AstraZeneca Adds Data Supporting Expanded Use of Its Drugs in Lung Cancer What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine Moderna And Merck Advance Cancer Treatment With Promising Vaccine NHS patients in England to be offered trials for world-first cancer vaccine Thousands of cancer patients to trial personalised vaccines Panel – Jack Young, Jen Burke, Ollie May Research & Production – Jack Young, Karan Pandya Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Accelerating Your Journey Into the Era of AI
Jun 6 2024
Accelerating Your Journey Into the Era of AI
As healthcare organizations strive to accelerate innovations through Artificial Intelligence (AI), it can be complicated to navigate through the number of possibilities that exist and know how to get started. In this episode, Jen is joined by Vynamic’s Tech & Digital Transformation Service Lead, Vince Annerhed-Harris and Lantern’s Chief Experience Officer, Brian Sturgeon, to discuss how healthcare leaders can plot the course for their AI journey and prioritize their investments to better accelerate their business objectives utilizing AI tools. Podcast Tags: health, healthcare, healthcare news, generative AI, innovation, responsible use, tech transformation, digital transformation  Source Links: The AI Strategy Roadmap: Navigating the stages of value creation | The Microsoft Cloud Blog Introducing: Lantern – A Digital Innovation Consultancy Designed for the Era of AI (youtube.com) A Practical Guide to Enabling AI within your Organization. (youtube.com)   Reimagining Technology Consulting for the Era of AI – Lantern (lanternstudios.com) Panel – Jen Burke, Vince Annerhed-Harris, Brian Sturgeon Research & Production – Everly Petruzzelli, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For more information on Lantern, please visit: Lantern – Microsoft Solutions Partner (lanternstudios.com), Lantern’s LinkedIn Page, Build and Modernize AI Apps – Microsoft Azure Marketplace If you want to learn more about implementing AI within your organization, you can check out Vynamic | Tech & Digital Transformation | Health Industry Consulting For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
NHS’s Cybersecurity Problem, A Win for Psilocybin Research
May 16 2024
NHS’s Cybersecurity Problem, A Win for Psilocybin Research
In this Trending News Europe episode, Jack, Jen, and Ollie discuss a few recent newsworthy items, including an increase in cyberattacks on the healthcare sector, Europe’s plan to future-proof its Biotech Sector and New Research from the University of Oxford into psilocybin as a potential treatment for depression. Podcast Tags: healthcare, healthcare news, life sciences, NHS, cybersecurity, biotech, research & development, pharmaceuticals, depression, psilocybin, mental health, psychedelics, mental health awareness week Source Links: ’Large volume’ of data stolen from NHS Dumfries and Galloway published on dark web Huge volume of NHS patient and staff data released by hacker NHS cyber attack: Why stolen medical information is so much more valuable than financial data Cyber attacks are one of the biggest threats facing healthcare systems Government Launches NHS Cyber Security Strategy US tech group Palantir wins lucrative NHS data contract Patient privacy fears as US spy tech firm Palantir wins £330m NHS contract European Commission lays down path to future-proof EU biotechnology Roche to buy Carmot for up to $3.1bn as race for obesity drugs intensifies Roche agrees $7.1bn deal for Telavant to boost drug pipeline  Europe’s biotech innovation in the balance Commission takes action to boost biotechnology and biomanufacturing in the EU Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis EU launches landmark €6.5M study on use of psychedelics to treat mental disorders Magic mushrooms’ psilocybin can alleviate severe depression when used with therapy Psychedelic drug research held back by UK rules and attitudes, say scientists King’s College Psychoactive Trials Group Panel – Jack Young, Jen Burke, Ollie May Research & Production – Karan Pandya, Jack Young Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
The Benefits of Early Launch Planning
May 9 2024
The Benefits of Early Launch Planning
As competitive and regulatory pressures increase, Life Sciences organizations are tightening their timelines and budgets when bringing products to market. In this environment, it’s become essential to start commercialization planning earlier to ensure a successful launch and hit revenue targets. In this deep dive episode, Jen is joined by Vynamic’s Product Launch Service Leads, Ashley Stanley and Brian Stamm, as well as Managing Director of PROPENSITY4, Chris Savage, to discuss why early planning is so critical and how leaders can incorporate some of these changes into their organizations.  To learn more about Vynamic’s work in Product Launch, visit Vynamic’s Product Launch page. To read more on navigating alliance product launches, see Vynamic’s latest insight here.  PROPENSITY4, part of Inizio Engage, is transforming pharmaceutical commercialization through seamless integration of data, expertise and cutting-edge analytics. See more about what PROPENSITY4 can do for your team at Data and Integrated Insights | Inizio Engage.  Podcast Tags: healthcare, life sciences, product launch, healthcare news, life sciences trends, product launch trendsSource Links:Product launch challenges and how to overcome themDrug launches reflect overall company performanceTO SPEND OR NOT TO SPEND: Investing For Launch Success As An Emerging CompanyRevenue of the worldwide pharmaceutical market from 2001 to 2023Prices for new US drugs rose 35% in 2023, more than the previous yearNext in pharma 2024: Reinventing for returnsThe Unbearable Cost of Drug DevelopmentUnderstanding the Factors that Impact the Pre-Launch Phase and New Product Launch Excellence in the Pharmaceutical IndustryFDA Approves Many New Drugs in 2023 that Will Benefit Patients and ConsumersPanel – Jen Burke, Ashley Stanley, Chris Savage, Brian StammResearch & Production – Adrea Cope & Everly PetruzzelliRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
From Ambition to Action: AI in the Health Industry
Apr 25 2024
From Ambition to Action: AI in the Health Industry
While the health industry is not always an early adopter of new technologies, the growth of generative artificial intelligence (GenAI) has empowered organizations to start transforming their AI aspirations into actions. In this episode, Mindy and Jen are joined by Vynamic’s Innovation Lead, Michael Hudson, and Responsible AI Lead, Todd Quartiere, to discuss where we see health organizations experimenting with AI and what it will take for them to achieve their long-term AI ambitions.To learn more about implementing AI within your organization, check out our recent insight: Why AI fails or flourishes: The underestimated role of culture.Podcast Tags: health, healthcare, healthcare news, generative AI, innovation, responsible use, ChatGPTSource Links:The Unexpected Winners of the ChatGPT Generative AI Revolution Generative AI in healthcare: Emerging use for care US healthcare leadership: How to respond and thrive How Can AI Improve Health Care? Envisioning Healthcare in a Post-COVID-19 World Three-quarters of health professionals project widespread AI adoption 5 Key Healthcare Industry Trends to Watch in 2024 What Do We Mean When We Talk About “AI Democratisation”?  Panel – Jen Burke, Michael Hudson, Mindy McGrath, Todd QuartiereResearch & Production – Danielle Lewis, Jen BurkeRecording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Trending News Europe – 18 April 2024
Apr 18 2024
Trending News Europe – 18 April 2024
In this Trending News Europe episode, Jack, Jen, and Ollie discuss recent newsworthy items from across Europe, including the impact of and deterrents against “no shows” at medical appointments, the role bacteria play in cancer treatment, and inequalities in the rare disease market, along with the steps being taken to ease these issues.Podcast Tags: healthcare, healthcare news, life sciences, public health, France, medical, bacteria, cancer, immunotherapy, chemotherapy, microbiome, rare disease, Germany, Italy, health disparity  Source Links:Dutch hospitals use AI to solve no-show patient problems that cost them millions  Cancellations of NHS care are having serious impacts on two-thirds of patients  Would charging patients for missed appointments help fund the NHS?  GP \’no shows\’ cost Norfolk NHS more than 1m in a one month  France planning €5 no-show fees in a bid to improve community healthcare  France divided over ‘no-show tax’ for patients failing medical appointments   Researchers compile detailed catalog of bacteria living in cancer metastases  Boehringer builds out cancer capabilities with $500M deal for bacteria-focused Swiss biotech  The key to young onset bowel cancer may be gut bacteria  The mystery of microbes that live inside tumours  Diversity of Bacteria in Cancer Metastases  It’s the Little Things: A Role for Bacteria in Cancer Treatment   The UK is missing out on EU collaboration to improve treatment for rare diseases  Overcoming the burden of rare diseases in Europe  Stronger together in the fight against rare diseases  Is Europe on track to be the leader in rare diseases?  Right here, right now European public health policies must start giving people living with rare diseases a fair chance  New rare diseases action plan on horizon, Europe at turning point  Europe needs new 360 rare diseases strategy   Panel – Jack Young, Jen Burke, Ollie May  Research & Production – Karan Pandya  Recording & Editing – Mike Liberto, Rachel Skonecki   For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Sustainability in Life Sciences
Apr 11 2024
Sustainability in Life Sciences
In recent years, we’ve seen an increasing number of Life Sciences companies publicly declare commitments to sustainability efforts as a result of increased pressure from governments, customers, and research. Trending Health UK’s Ollie May sits down with two members of Vynamic’s Sustainability Council, Rosanna Vellacott and Matt O’Dell, to discuss why pharmaceutical organizations should be paying attention to sustainability goals, some innovative practices underway, and what leaders should be considering as they embed more sustainable practices into their organizations.  Podcast Tags: healthcare, life sciences, sustainability, healthcare news, climate change, climate crisis, emissions, net zero, supply chain    Source Links:  Striving for sustainable drug discovery using Green Chemistry Accelerating the transition to net zero in life sciences Process Digital Twin for Pharma Sanofi harnesses Dassault\’s digital twin tech to optimize production at future vaccine plants Strategies for Sustainability in the Global Pharmaceutical Supply Chain Bayer: Improving Sustainability Practices in the Supply Chain Bayer: Commitments in Action Creating a Sustainable Product Supply Making biopharma’s supply chains more environmentally sustainable The pharma companies working towards supply chain sustainability Carbon footprint of the global pharmaceutical industry and relative impact of its major players The Greenhouse Gas Protocol: Technical Report  Understanding pharma’s challenges and opportunities in relation to the climate crisisPharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies Pharma’s path to Net Zero: Targeting Scope 3 emissions   Panel – Oliver May, Rosanna Vellacott, Matt O’Dell  Research & Production – Adrea Cope, Everly Petruzzelli, Oliver May   Recording & Editing – Mike Liberto, Rachel Skonecki    For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Trending News Europe – 21 March 2024
Mar 21 2024
Trending News Europe – 21 March 2024
In this episode, Jack, Ollie, and Jen discuss a substantial investment package in the UK’s Life Sciences and manufacturing sectors, the role of an AI chatbot in bridging Europe\’s mental health care gap, and how Spain is reshaping pharmaceutical supply chains in Europe. Podcast Tags: healthcare, Europe, healthcare news, manufacturing, research, AI, chatbots, mental health, patient care, Spain, supply chain Source Links: UK lacks plans to make pandemic vaccines quickly, MPs hear Spring Budget puts UK on fast-track to becoming science and technology superpower UK Spring Budget allocates funds to life sciences manufacturing £360 million to boost British manufacturing and R&D ABPI response to the Budget UK Chancellor trumpets £650m AstraZeneca investment Meet the AI chatbot therapists filling the gaps in Europe’s mental health care shortfall Mental health services facing ‘vicious cycle’ workforce issue A chatbot helped more people access mental-health services Closing the accessibility gap to mental health treatment with a personalized self-referral chatbot A child in Poland has to wait 238 days to see a psychiatrist, activist says From ‘crisis’ to ‘pandemic’: mental health in Europe Europe\’s mental health crisis: Which country uses the most antidepressants? Belgium leads the charge on the EU’s medicines reshoring plans EU capitals propose Chips Act for medicines Onshoring and global health – has the pandemic sent globalisation into reverse? France\’s Emmanuel Macron seeks to relocate domestic production of key drugs to avoid shortages Barcelona identified as Europe’s second-best hub for biotech investment Moderna opens international centre for analytical excellence in Madrid Spain showing great pharma potential as Barcelona named Europe’s No.2 hub for biotech investment Spain Has All the Right Elements To Become a Fast-Growing Life Science Hub Spain’s plan to become Europe’s pharmaceutical epicentre  Panel – Jack Young, Jen Burke, Ollie MayResearch & Production – Jack Young, Karan Pandya, Ollie MayRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Obesity Drug Market: Opportunities and Obstacles
Mar 14 2024
Obesity Drug Market: Opportunities and Obstacles
The obesity drug market has grown dramatically in the last few years, especially with the help of social media and influencers. The immense popularity of anti-obesity medications has transformed a health industry development into a cultural phenomenon. While this market has so much opportunity, it also faces supply issues and coverage gaps. Mindy and Jen are joined by Vynamic’s Head of Life Sciences, Karen Baldry, and Head of Health Plans, Saurabh Raman, to talk about the growth and challenges obesity medications present for the health industry.Podcast Tags: healthcare, obesity, weight loss, diabetes, health services, health plans, life sciences  Source Links: What Is Ozempic and Why Is It Getting So Much Attention? We Know Where New Weight Loss Drugs Came From, but Not Why They Work What the Scientists Who Pioneered Weight-Loss Drugs Want You to Know Supply Updates about WegovyThe increase in appetite for obesity drugs Demand for GLP-1 drugs is growing. Here\’s why payers are hesitant to cover them for weight loss More than 4,000 ads for Ozempic-style drugs found running on Instagram and Facebook  Wegovy heart health data is promising — but insurers face long road, high cost to cover obesity drugs Medicare is barred from paying for weight-loss drugs like Wegovy. Lawmakers just took the first step to change that Cost isn’t the only reason Medicare doesn’t cover WegovyNew marketing push by Ozempic and others sparks body-positive backlash What You Need to Know About Compounded Versions of Popular Weight Loss Drugs Novo antes up $16.5B to poach CDMO giant Catalent amid Wegovy surge  Wegovy, other GLP-1s could lower heart disease: Study  Novo kidney trial finds Ozempic cuts cardiac deaths in diabetics  How Ozempic and Weight Loss Drugs Are Reshaping Denmark’s Economy  Novo Nordisk\’s Wegovy bonanza looms large in Denmark  Big pharma’s blockbuster obesity drug battle is just getting started, and it’s headed for $100 billion  Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect  Ozempic vs Wegovy Obesity drug boom pushes Novo Nordisk shares to record high Popular use of obesity drugs like Ozempic could change consumer habits Panel – Jen Burke, Mindy McGrath, Karen Baldry, Saurabh Raman Research & Production – Adrea Cope, Everly Petruzzelli Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Trending News Europe – 22 February 2024
Feb 22 2024
Trending News Europe – 22 February 2024
In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, covering a prominent oncology society\’s push for tumor classification reform that could have profound impacts on cancer survival rates, the critical need for measles vaccination, and Sweden\’s pioneering use of drones in cardiac arrest intervention. Podcast Tags: healthcare, healthcare news, life sciences, precision oncology, cancer, molecular testing, infectious diseases, vaccination, NHS sustainability, innovation, Sweden Source Links:We’re naming cancers all wrong, oncology leader says  Forget lung, breast or prostate cancer: why tumour naming needs to change Redefining Cancer Classification: A Shift from Organ-based to Molecular-based Approach A 30-fold rise of measles cases in 2023 in the WHO European Region warrants urgent action Measles in Europe: WHO calls for ‘urgent’ vaccinations as cases surge Europe Needs to Get on Top of Its Measles Outbreak Europe faces resurgence of measles due to low vaccination coverage Europe\’s first transport of blood bags by drone takes place in Belgium NHS to pioneer drone deliveries in bid to improve service Drone chemotherapy becomes an NHS net zero cancer strategy Sweden uses drones to fight cardiac arrest Healthcare From Above: Challenges And Opportunities Of Medical Drones Flight Trials for Scots Medicine-carrying Drones Conducted Government to invest £30 million in innovative technology for NHS Department of Health and Social Care: Medical Technology Strategy Drones to deliver NHS medication to care homes and GP surgeries in major roll-out NHS to begin delivering critical medical supplies by drone Panel – Jack Young, Jen Burke, Ollie MayResearch & Production – Jack Young, Karan Pandya, Ollie MayRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
MedTech Market Moves
Feb 15 2024
MedTech Market Moves
Over the last few years, the MedTech market has been navigating an unpredictable environment due to macro-economic factors and pandemic-driven activity. As we start off 2024, there’s a prevailing feeling that this market is finally starting to stabilize. In this episode, Jen is joined by Vynamic’s Anila Patel and Head of Health Technology Sector, Mary Virzi, to chat about what MedTech moves we’ve seen so far and what we can expect as 2024 kicks into gear.  Podcast Tags: healthcare, medtech, product launch, medical device, health tech, healthcare technology Source Links: The biggest stories from the 2024 J.P. Morgan Healthcare Conference 5 medtech trends to watch in 2024 MEDTECH AND DIAGNOSTICS MARKET: 2023 TRENDS AND 2024 OUTLOOK Medtronic aims to leverage medical device data for AI-enabled care 4 heart device trends shaping the medtech sector in 2024 J&J\’s Biosense Webster puts forward pulsed field ablation data showing no afib after one year Boston Scientific nets Farapulse approval, pushes back US TAVR launch J&J\’s Biosense Webster puts forward pulsed field ablation data showing no afib after one year Medtronic snags first pulsed field ablation approval in US Spotlight – J&J takes on Medtronic and Boston in pulsed field ablation Increasing diabetes awareness boosts the diabetes care devices market Panel – Mary Virzi, Anila Patel, Jen Burke Research & Production – Adrea Cope, Everly Petruzzelli Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Trending News US – February 8, 2024
Feb 8 2024
Trending News US – February 8, 2024
In this episode, Jen sits down with Vynamic’s Deal Activation & Partnership Enablement Service Leads, Senior Director Kevin Fletcher and Executive Sean Martin, to discuss recent newsworthy items coming out of the J.P. Morgan Healthcare Conference, including the major acquisitions and deals announced, particularly those focused on AI and digital innovation.Check out Vynamic’s Deal Activation & Partnership Enablement Service page to learn more about how Vynamic helps clients manage critical, time-sensitive activities across the deal life cycle. Podcast Tags: healthcare, healthcare news, life sciences, pharmaceutical, JP Morgan, deal activation, partnerships, mergers, acquisitions, AI, digital innovation Source Links: Inizio Biotech key takeaways from JPM industry event Cigna sells Medicare business to Health Care Service for $3.3 bln Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics J&J, Merck and Boston Scientific Go on $6.4 Billion Buying Spree Amazon rolls out digital health benefits program, taps Omada Health as launch partner What the Health Care Sector Was Selling at the J.P. Morgan Confab Jefferson Health says LVHN merger would double its insurance business within 2 years Panel – Jen Burke, Kevin Fletcher, Sean Martin Research & Production – Anna Briccetti, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.